Literature DB >> 7545322

Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis.

H Schrezenmeier1, H Müller, E Gunsilius, H Heimpel, E Seifried.   

Abstract

Pseudothrombocytopenia (PTP) is the phenomenon of falsely low platelet counts due to in vitro platelet clumping in the presence of platelet autoantibodies and anticoagulants. We assessed anticoagulant-dependence, time course of platelet counts and impact of different counter devices on the phenomenon. Blood of 10 persons with previously recognized pronounced EDTA-dependent PTP was collected into 7 different anticoagulants and counted after different intervals in parallel in a Coulter T540 and a Coulter STKS counter and by phase contrast microscopy. With the Coulter T540 model PTP was most pronounced in blood samples anticoagulated with EDTA, Na-oxalate or Na-citrate. In the STKS counter EDTA, heparin and oxalate presented as the worst anticoagulants. The time course of platelet counts was significantly different between the two counters. Our results demonstrate that PTP is not restricted to EDTA, but is also present with other anticoagulants. In contrast, pseudoleucocytosis was observed only in EDTA-anticoagulated blood in the Coulter T540 device. We investigated the expression of platelet integrins and activation antigens on platelets of persons with anticoagulant-dependent PTP and in healthy controls without PTP. In the presence of EDTA the expression of GpIIb/IIIa was significantly reduced in the PTP subjects compared to control. Activation antigens CD62, CD63 and thrombospondin-antigen were upregulated in the presence of EDTA. These alterations in the expression of platelet antigens could also be induced on platelets of normal donors by incubation with sera of PTP subjects and EDTA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545322

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

Review 1.  [Adult autoimmune thrombocytopenia: diagnosis and treatment].

Authors:  Klaus Lechner; Ansgar Weltermann; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

Review 2.  Idiopathic thrombocytopenic purpura: pathophysiology and management.

Authors:  Yeon S Ahn; Lawrence L Horstman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.

Authors:  Peter Schuff-Werner; Michael Steiner; Sebastian Fenger; Hans-Jürgen Gross; Alexa Bierlich; Katrin Dreissiger; Steffen Mannuß; Gabriele Siegert; Maximilian Bachem; Peter Kohlschein
Journal:  Br J Haematol       Date:  2013-06-29       Impact factor: 6.998

4.  Autoimmune Thrombocytopenia Complicated by EDTA- and/or Citrate-Dependent Pseudothrombocytopenia.

Authors:  Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-08-04       Impact factor: 3.747

5.  [A non-EDTA-dependent pseudothrombocytopenia: about a case].

Authors:  Hicham Titou; Youssef Jalal; Mohammed Boui
Journal:  Pan Afr Med J       Date:  2017-02-22

6.  A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon.

Authors:  Michael Nagler; Peter Keller; Daniel Siegrist; Lorenzo Alberio
Journal:  BMC Clin Pathol       Date:  2014-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.